Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;6(6):485-6.
doi: 10.1111/cts.12057. Epub 2013 Apr 19.

Rate of change of carotid intima-media thickness with magnesium administration in Abcc6⁻/⁻ mice

Affiliations

Rate of change of carotid intima-media thickness with magnesium administration in Abcc6⁻/⁻ mice

Erine A Kupetsky et al. Clin Transl Sci. 2013 Dec.

Abstract

Pseudoxanthoma elasticum (PXE), caused by mutations in the ABCC6 gene, demonstrates progressive build-up of calcium phosphate and proteoglycans in the skin, eye, and arteries, and is associated to myocardial infarctions, stroke, blindness, and elevated carotid intima-media thickness (CIMT). Although CIMT reduction with magnesium (Mg) has been documented in a mouse model for PXE (Abcc6(-/-) ), it is not clear if Mg is effective in humans with PXE to reduce CIMT. To examine this, we calculated the rate of change of CIMT (washout) in 15- and 12-month-old Abcc6(-/-) mice fed standard rodent diet with or without Mg supplementation for 2 months. Using means in untreated 15- and 12-month-old Abcc6(-/-) mice (145 and 120 μm, respectively), the rate of change was 8.3 μm/month. Using means in treated 15- and 12-month-old Abcc6(-/-) mice (118 and 104.6 μm, respectively), the rate of change was 4.5 μm. Compared to normal progression of CIMT in humans without PXE, PXE has advanced atherosclerosis and possibly a higher CIMT rate of change. This experiment may portend, at least in PXE, the rationale for a 1-year oral Mg CIMT clinical trial and may be useful for application in other progressive mineralizing disorders like atherosclerosis.

Keywords: arteriosclerosis; cardiovascular diseases; carotid arteries; nutrition; stroke.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Oral magnesium (Mg) administration reduced CIMT in Abcc6−/− mice and the rate of CIMT change is measurable in this mineralizing disorder. (A) 12‐month‐old carotid artery section from wild type (WT, Abcc6+/+) controls (untreated).10 (B) 12‐month‐old carotid artery section from knockout (KO) controls (untreated; p < 0.009 compared to [A]).10 (C) 12‐month‐old carotid artery section from WT‐treated. (D) 12‐month‐old carotid artery section from KO treated with 2 months of oral Mg (p < 0.02 compared to [B]).10 (E) 15‐month‐old carotid artery section from a KO control mouse (untreated). (F) 15‐month‐old carotid artery section from KO mouse treated 2 months on, 2 months off with Mg (p < 0.011 compared to [E]). The mean value in (F), 118 μm, as well as the individual value shown, 119 μm, were similar to that of (B), the 12‐month‐old Abcc6 −/− untreated group, mean 120 μm. The bar represents 100 μm.

References

    1. PXE and Cardiology . PXE International. 2011. http://www.pxe.org/pxe‐cardiology. Accessed Sept 9, 2012.
    1. Boutouyrie P, Germain DP, Tropeano AI, Laloux B, Carenzi F, Zidi M, Jeunemaitre X, Laurent S. Compressibility of the carotid artery in patients with pseudoxanthoma elasticum. Hypertension 2001; 38: 1181–1184. - PubMed
    1. Germain DP, Boutouyrie P, Laloux B, Laurent S. Arterial remodeling and stiffness in patients with pseudoxanthoma elasticum. Arterioscler Thromb Vasc Biol. 2003; 23: 836–841. - PubMed
    1. Kornet L, Bergen AA, Hoeks AP, Cleutjens JP, Oostra RJ, Daemen MJ, van Soest S, Reneman RS. In patients with pseudoxanthoma elasticum a thicker and more elastic carotid artery is associated with elastin fragmentation and proteoglycans accumulation. Ultrasound Med Biol. 2004; 30: 1041–1048. - PubMed
    1. Peters SA, den Ruijter HM, Bots ML. Attenuation of rate of change in carotid intima‐media thickness by lipid‐modifying drugs: impact on clinical outcomes. Am J Cardiovasc Drugs 2011; 11: 253–263. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources